Skip to main content
Back to New Enterprise Associates

New Enterprise Associates's Therapeutics Portfolio

Browse 9 Therapeutics companies funded by New Enterprise Associates. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
9
Total Funding in Therapeutics
$684.2M

Therapeutics Portfolio Companies (9)

Export
BiotechnologyHealth CareTherapeutics

Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor pathways.

San Francisco, United States
May 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.

Foster City, United States
May 2026
Post-IPO Debt

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalOncologyTherapeutics

Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.

San Diego, United States
September 2025
$60.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

SetPoint Medical provides a device-based therapy for rheumatoid arthritis.

Valencia, United States
August 2025
$115.0M
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Allay Therapeutics offers analgesic products for post-surgical pain management and recuperation.

San Jose, United States
June 2025
$57.5M
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Tune Therapeutics is an epigenetic programming platform for the treatment of disease.

Durham, United States
January 2025
$175.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical DeviceTherapeutics

FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.

Dublin, Ireland
January 2025
$120.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

Health CareMedicalPharmaceuticalTherapeutics

Orbis Medicines is a novel macrocyclic chemistry and computational platform for oral macrocycle drug discovery.

Frederiksberg, Denmark
January 2025
$93.2M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareTherapeutics

MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.

Carmel, United States
August 2024
$63.5M
Series C

Founder Contacts

19,000+ verified contacts

Explore New Enterprise Associates's Full Portfolio

View all companies funded by New Enterprise Associates across every industry and funding stage.

View Full New Enterprise Associates Portfolio